Sunnergren K P, Rovetto M J
Microvasc Res. 1985 Nov;30(3):286-97. doi: 10.1016/0026-2862(85)90060-3.
Hyaluronic acid, a principal glycosaminoglycan of the cardiac interstitium, may have a role in interstitial hydration, interstitial plasma protein exclusion and microvascular transport process (Wiederhielm, 1976b). We have investigated whether hyaluronidase reduces myocardial hyaluronate concentrations and thereby alters these several physical aspects in the isolated rat heart. Studies were conducted in ischemic, as well as aerobic hearts because of the reported therapeutic efficacy of the enzyme in myocardial ischemia. Two hours of perfusion with hyaluronidase significantly reduced myocardial hyaluronate content. Additionally, hyaluronidase decreased interstitial volume of both aerobic and otherwise edematous ischemic hearts, and prevented ischemic induced increased coronary vascular resistance in ischemic hearts. However, hyaluronidase did not effect the albumin interstitial exclusion volume or microvascular albumin and sorbitol exchange in aerobic hearts. In ischemic hearts, the enzyme did not prevent nor enhance the increase in microvascular permeability which occurred. We conclude that hyaluronate is neither a determinant of interstitial protein exclusion nor microvascular permeability, but plays an important role in interstitial hydration.
透明质酸是心脏间质的主要糖胺聚糖,可能在间质水化、间质血浆蛋白排斥和微血管运输过程中起作用(Wiederhielm,1976b)。我们研究了透明质酸酶是否会降低心肌透明质酸盐浓度,从而改变离体大鼠心脏的这些物理特性。由于该酶在心肌缺血方面已报道的治疗效果,我们在缺血心脏以及有氧心脏中进行了研究。用透明质酸酶灌注两小时可显著降低心肌透明质酸盐含量。此外,透明质酸酶可降低有氧心脏和水肿性缺血心脏的间质容积,并防止缺血心脏中缺血诱导的冠状动脉血管阻力增加。然而,透明质酸酶对有氧心脏中的白蛋白间质排斥容积或微血管白蛋白及山梨醇交换没有影响。在缺血心脏中,该酶既不能阻止也不能增强发生的微血管通透性增加。我们得出结论,透明质酸盐既不是间质蛋白排斥的决定因素,也不是微血管通透性的决定因素,但在间质水化中起重要作用。